Search

everythinglearnresearchcommunity

for

Search:↓

Minoxidil breakdown varies by enzymes, affecting hair loss treatment effectiveness.

Obese women with PCOS show a male-like pattern in certain fat tissue gene expressions.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

Using finasteride or dutasteride may cause long-lasting erectile dysfunction.

The review found no clear link between vitamin D receptor gene variations and polycystic ovary syndrome.

Men with frontal male pattern baldness may have a higher risk of gastric cancer.

Using rodents for research shows that health problems in the womb can cause diseases later in life.

The conclusion is that hair loss in women is caused by a mix of hormonal, environmental, and genetic factors, and treatments should target these various causes.

Doctors recommend postoperative radiation for male breast cancer, advise against testosterone for vasomotor symptoms post-adrenalectomy, suggest non-hormonal treatments for atrophic vaginitis after mastectomy, note no specific treatment for anticoagulant-induced hair loss, and call for more research on silicosis from silicon carbide exposure.

Finasteride may effectively treat hair loss in Klinefelter Syndrome patients.

The conclusion is that proper signaling is crucial for hair growth and development, and errors can lead to cancer or hair loss.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Estrogen can temporarily slow down hair growth but this can be reversed.

Women with only irregular periods or excess hair have a better hormone profile than those with full PCOS, but both groups are similar, indicating a need for better PCOS diagnosis methods.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

The conclusion suggests that PCOS may persist due to genetic traits that, while harmful for female fertility, could have provided survival and reproductive benefits to males.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Combination therapy with oral contraceptives and spironolactone improves hair growth, menstrual issues, and acne in women with PCOS.

A woman with anorexia and Cushing's syndrome improved after tumor removal, highlighting the need to consider hormonal issues in psychiatric conditions.

Glucocorticoids and sex hormones affect skin health, with potential for targeted treatments to minimize side effects and treat skin conditions.

Manage women's cholesterol with diet, exercise, and careful treatment choices, especially during pregnancy, PCOS, and menopause.

Many males in Jordan misuse oral contraceptive pills for hair growth, muscle gain, and acne treatment.

Men have worse COVID-19 outcomes than women due to genetic and hormonal differences.

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

Tamoxifen effectively treats gynecomastia without causing impotence.

Women with AGA have more androstenedione and dihydrotestosterone, less copper and zinc; copper imbalance affects AGA; treatment improves hormones and minerals.

SHBG binding properties are unchanged in male liver cirrhosis patients.

Taking vitamin B6 corrected a pregnant woman's metabolic disorder, which changed her hair color.

The conclusion is that published guidelines are improving transgender medical care, but more research and education in transgender medicine are needed.